全科医生初始切除黑色素瘤是否危险?基于全国数据集与荟萃分析的患者结局比较
该研究基于苏格兰2005—2013年9367例黑色素瘤登记数据,比较全科医生与医院初始切除后的死亡与就诊结局,并纳入爱尔兰7116例进行荟萃分析。调整后全科医生切除的黑色素瘤死亡HR为0.82(0.61-1.10),荟萃分析以初级保健为参照,二级保健切除的全因死亡HR为1.26(1.07-1.50)。结果提示初级保健初始切除未显示更差生存或更多就诊。
要点
- 全科医生初始切除黑色素瘤的调整死亡HR为0.82(0.61-1.10),未见生存劣势。
- 荟萃分析以初级保健为参照,二级保健切除全因死亡HR为1.26(1.07-1.50)。
- 两组门诊就诊与住院次数差异无统计学意义。
核心结论
- 苏格兰分析与荟萃分析提示,初级保健初始切除黑色素瘤的患者生存和就诊负担不劣于二级保健初始治疗者。
研究设计与样本
- 基于苏格兰癌症登记2005—2013年9367例黑色素瘤患者,链接病理、住院和死亡记录进行回顾性队列分析。
- 采用Cox比例风险回归调整关键混杂因素,比较初级与二级保健初始切除的死亡和就诊结局。
- 纳入爱尔兰类似研究7116例患者进行荟萃分析,以初级保健为参照合并调整死亡风险比。
主要发现
- 初级保健切除黑色素瘤的调整死亡HR为0.82(95%CI 0.61-1.10)。
- 初级保健组门诊就诊中位数8次(IQR 3-14),二级保健组10次(IQR 4-17),调整RR为0.98(95%CI 0.96-1.01)。
- 两组住院中位数均为1次(IQR 0-2),调整率比为1.05(95%CI 0.98-1.13)。
- 荟萃分析以初级保健为参照,二级保健切除的全因死亡合并调整HR为1.26(95%CI 1.07-1.50)。
临床怎么用
- 结果不支持全科医生初始切除黑色素瘤必然导致劣质照护或生存威胁的假设。
- 作者认为有必要开展随机对照试验,以明确全科医生在黑色素瘤初始切除中的更大作用。
局限性
- 原文未系统报告本研究的具体局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Melanomas are initially excised in primary care, and rates vary internationally. Until now, there has been no strong evidence one way or the other that excising melanomas in primary care is safe or unsafe. European guidelines make no recommendations, and the United Kingdom (UK) melanoma guidelines require all suspicious skin lesions to be initially treated in secondary care based on an expert consensus, which lacks supporting evidence, that primary care excision represents substandard care. Despite this, studies have found that up to 20% of melanomas in the UK are excised by general practitioners (GPs). Patients receiving primary care melanoma excision may fear that their care is substandard and their long-term survival threatened, neither of which may be justified. METHODS: Scottish cancer registry data from 9367 people diagnosed with melanoma in Scotland between 2005 and 2013 were linked to pathology records, hospital data and death records. A Cox proportional hazards regression analysis, adjusting for key confounders, explored the association between morbidity and mortality and setting of primary melanoma excision (primary versus secondary care). A pooled estimate of the relative hazard of death of having a melanoma excised in primary versus secondary care including 7116 patients from a similar Irish study was also performed. RESULTS: The adjusted hazard ratio (95% CI) of death from melanoma for those having primary care excision was 0.82 (0.61-1.10). Those receiving primary care excision had a median (IQR) of 8 (3-14) out-patient attendances compared to 10 (4-17) for the secondary care group with an adjusted relative risk (RR) (95% CI) of 0.98 (0.96-1.01). Both groups had a median of 1 (0-2) hospital admissions with an adjusted rate ratio of 1.05 (0.98-1.13). In the meta-analysis, with primary care as the reference, the pooled adjusted hazard ratio (HR, 95% CI) was 1.26 (1.07-1.50) indicating a significantly higher all-cause mortality among those with excision in secondary care. CONCLUSIONS: The results of the Scottish and pooled analyses suggest that those receiving an initial excision for melanoma in primary care do not have poorer survival or increased morbidity compared to those being initially treated in secondary care. A randomised controlled trial to inform a greater role for GPs in the initial excision of melanoma is justified in the light of these results.
引用
- Murchie P, Amalraj Raja E, Brewster DH, et al. Is initial excision of cutaneous melanoma by General Practitioners (GPs) dangerous? Comparing patient outcomes following excision of melanoma by GPs or in hospital using national datasets and meta-analysis. Eur J Cancer. 2017. PMID: 29100192. doi:10.1016/j.ejca.2017.09.034
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。